- Phase I
- Phase II/III
- Therapeutic expertise
- Rescue services
- Technology solutions
- Comprehensive capabilities
- News &
Inner-City Asthma Study (ICAS)
Taking health care where it’s needed most
The Inner-City Asthma Study (ICAS) is a seven-site cooperative study sponsored by the National Institute of Allergy and Infectious Diseases and the National Institute of Environmental Health Sciences. The Inner-City Asthma Study was designed to evaluate the effectiveness of two types of interventions at reducing asthma morbidity and severity among 937 inner-city children, aged 5 to 11, with moderate to severe asthma. Each participant was enrolled for 2 years: the intervention year and the follow-up year.
The physician feedback intervention used a novel communication and education system that provided physicians with up-to-date information on the child’s symptoms, medication use, and health care use. The intervention, aimed at physicians caring for children in poor urban communities, successfully changed provider behavior, reducing emergency department asthma visits and associated health care costs.
The environmental intervention focused on the home environments of the children, involving education and remediation of environmental exposures including cockroaches, dust mites, environmental tobacco smoke, mold, furry pets, and rodents. The intervention, tailored to each child’s sensitization and environmental risk profile, decreased reported symptoms among the children.
The ICAS data coordinating center is managed by Herman Mitchell, Ph.D., Vice President, Federal Operations.
This is a closed project.